Install
Zacks Small Cap Research coverage specifically looks to focus on small and micro-cap companies that are under followed or under valued by Wall Street.
- 38articles · 30d
- 3+ day agolatest article
- Aug 17, 2026earliest in window
- 0%with images
- 298avg words
- Economy, Business & Finance 33
- Finance & Business 25
- News 21
- Health & Wellness 10
- Medical 8
- Business & Industrial 6
- Industrial 5
- Health 4
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
HCTI Spins off Teyame to Benefit Shareholders
3+ day, 13+ hour ago (134+ words) Those numbers help explain why separating Teyame into its own publicly traded company could be strategically significant. Creating an independently traded Teyame could change that dynamic. Once Teyame has its own listing, investors should have a much clearer market reference…...
GOTRF: Surebet Discovery Site Visit confirms our positive outlook for the project. Drilling continues to hit mineralization, expand the footprint, and remains open.
3+ day, 15+ hour ago (522+ words) //s27.q4cdn.com/906368049/files/pictures/2026/09102026_GOTRF_1.png GOTRF: Surebet Discovery Site Visit confirms our positive outlook for the project. Drilling continues to hit mineralization, expand the footprint, and remains open. In August 2026, the analyst travelled to northern British Columbia to conduct a due…...
BDMD: Baird Medical Reports Strong Revenue Growth for the 6-Month Period Ending 6/30/26
3+ day, 19+ hour ago (274+ words) By Tom Kerr, CFA READ THE FULL BDMD RESEARCH REPORT On September 3, 2026, Baird Medical (NASDAQ: BDMD) released financial results for the 6-month period ending June 30, 2026, which showed strong revenue growth from non-China regions. Cash level profitability also improved significantly. EBITDA…...
CPKF Posts Another Strong Quarter with Diluted EPS Up 75% Year over Year
4+ day, 19+ hour ago (278+ words) By Ann Heffron, CFA, CPA READ THE FULL CPKF RESEARCH REPORT Chesapeake Financial (OTCQX: CPKF) produced another strong quarter with 2026 second quarter net earnings surging $2.3 million, or 74%, to $5.5 million year over year, while 2026’s second quarter diluted EPS rose $0.50, or…...
LEXX: Introducing DehydraTECH 3.0
5+ day, 18+ hour ago (868+ words) //s27.q4cdn.com/906368049/files/pictures/2026/09082026_LEXX_1.png LEXX: Introducing DehydraTECH 3.0 Lexaria Bioscience Corp. (NASDAQ: LEXX) announced absorption data from its 2026 Animal Study #2 (GLP-1-A26-2). The canine study examined amycretin and retatrutide bioavailability using oral delivery compared to reference formats. 18 different study arms were evaluated,…...
UHAL: U-Haul Reported 1Q FY2027 Financial Results
5+ day, 19+ hour ago (334+ words) By Steven Ralston, CFA READ THE FULL UHAL RESEARCH REPORT On August 20, 2026, U-Haul held its 20th Annual Virtual Analyst and Investor Meeting, which was largely composed of answering analyst and investor questions. Highlights from the 20th Annual Virtual Analyst & Investor Meeting Toy…...
TNXP: $11.0 Million in Tonmya® Net Revenue in 2Q26
1+ week, 4+ day ago (233+ words) READ THE FULL TNXP RESEARCH REPORT $11.0 Million in Net Revenue for Tonmya® in 2Q26 Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is continuing the commercial launch of Tonmya® following its approval in August 2025 and commercial launch in November 2025. Sales metrics for the…...
CEO Chat with Tim Harrison, Managing Director of Ionic Rare Earths Limited
1+ week, 6+ day ago (679+ words) OTCQB: IXRRF ASX: IXR Tim Harrison: Hi Tom, good to be here. TK: I'm going to start with a series of questions. Before we get into your operations and your future development plans, some people may not be familiar with…...
ORMP: Investment Gains Contributed to Strong 2Q26 EPS, While Inclusion in Russell Indexes Arguably Boosts Awareness
2+ week, 2+ day ago (1239+ words) By M. Marin NASDAQ: ORMP READ THE FULL ORMP RESEARCH REPORT Gains on investment portfolio + service agreement income contributed to 2Q26 EPS of $2.76 Oramed Pharmaceuticals (NASDAQ: ORMP) leverages its strong balance sheet, with $15.2 million of cash and equivalents and $50.6 million of cash…...
MLPNF: Millennial Potash Drill Result Extends Potash Footprint Beyond the 2025 MRE
2+ week, 4+ day ago (440+ words) scr.zacks.com MLPNF: Millennial Potash Drill Result Extends Potash Footprint Beyond the 2025 MRE TSXV: MLP | OTCQB: MLPNF - Drillhole BA-006 has been completed. The hole intersected 80m of cumulative potash mineralization. - BA-006 extends the known mineralized footprint beyond the boundaries used…...